News
Menopause can lead to a variety of sleep ... A 2021 editorial suggests that CBT may reduce the impact of vasomotor symptoms, which include hot flashes and night sweats. Group CBT may also help ...
SSRI medications have come under scrutiny as of late, despite medical experts maintaining they're safe and effective.
The FDA submission is for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, based on three phase 3 studies showing that elinzanetant significantly reduced ...
autism and vasomotor symptoms associated with menopause. SSRIs are a subsection of the larger class of antidepressants. Other antidepressants usually prescribed for depression, according to NYU ...
Armed with new phase 3 data, Bayer has started preparing filings for elinzanetant as a treatment for vasomotor symptoms (VMS) associated with menopause, setting up a challenge to Astellas’ first ...
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms.
Fezolinetant is a first-in-class non-hormonal pharmacological treatment recently approved for moderate-to-severe vasomotor symptoms (VMS) associated with menopause. Its mechanism of action selectively ...
The Menopause Society. 2015;22(11):1155-1174.
Published in the Journal of Menopausal Medicine, the latest research validates ... Other insights from the study include: 24% decrease in presence and severity of vasomotor symptoms such as hot ...
Signs of Low Estrogen Many signs of low estrogen are related to female reproductive health and menopause, but there is a wide range of other causes of low estrogen including thyroid conditions and ...
Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ensure a comprehensive and personalized approach to managing osteoporosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results